Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1800 of 2529 entries
View as:

Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00720941 Org: User:
Start: 08/14/08 End: 03/24/21 Due: 03/24/22

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

Phase: N/A Priority: Normal
NCT ID: NCT05921994 Org: User:
Start: 08/10/23 End: 12/22/26 Due: 12/22/27

A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01677741 Org: User:
Start: 05/23/13 End: 12/04/20 Due: 12/04/21

Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT00867113 Org: User:
Start: 07/22/09 End: 12/20/16 Due: 12/20/17

A Prospective, Two-arm, Non-interventional Study of JAKAVI® (Ruxolitinib) in Patients With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05044026 Org: User:
Start: 09/20/12 End: 09/19/22 Due: 09/19/23

Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

Phase: N/A Priority: Normal
NCT ID: NCT05697146 Org: User:
Start: 12/13/22 End: 06/30/28 Due: 06/30/29

Dose-Escalation Study in Advanced Colon Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00969046 Org: User:
Start: 11/30/03 End: 11/30/06 Due: 11/30/07

38 Week Extension Study to CAIN457C2303

Phase: N/A Priority: Normal
NCT ID: NCT01093846 Org: User:
Start: 03/31/10 End: 01/31/11 Due: 01/31/12

Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01727024 Org: User:
Start: 04/30/13 End: 11/30/15 Due: 11/30/16

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01519661 Org: User:
Start: 01/31/12 End: 01/31/14 Due: 01/31/15

Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01294787 Org: User:
Start: 02/28/11 End: 11/30/11 Due: 11/30/12

Nationwide Trends in Incidence, Healthcare Utilization, and Mortality in Hospitalized Acute Myocardial Infarction Patients in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT05974397 Org: User:
Start: 09/30/21 End: 07/22/22 Due: 07/22/23

Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).

Phase: N/A Priority: Normal
NCT ID: NCT01090323 Org: User:
Start: 07/31/04 End: - Due: -

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Phase: N/A Priority: Normal
NCT ID: NCT02059291 Org: User:
Start: 06/27/14 End: 07/04/17 Due: 07/04/18

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Phase: N/A Priority: Normal
NCT ID: NCT05670106 Org: User:
Start: 05/16/23 End: 11/14/25 Due: 11/14/26

Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00667862 Org: User:
Start: 03/18/08 End: 11/05/10 Due: 11/05/11

Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia

Phase: N/A Priority: Normal
NCT ID: NCT00101712 Org: User:
Start: 10/31/04 End: 05/31/06 Due: 05/31/07

Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00529269 Org: User:
Start: 12/31/06 End: - Due: -

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Phase: N/A Priority: Normal
NCT ID: NCT04635800 Org: User:
Start: 12/10/20 End: 05/24/22 Due: 05/24/23

Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT01022970 Org: User:
Start: 11/30/09 End: - Due: -

Human Urine Sample Collection for Alport Nephropathy Biomarker Studies

Phase: N/A Priority: Normal
NCT ID: NCT01602835 Org: User:
Start: 09/30/12 End: 05/31/13 Due: 05/31/14

A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT06715254 Org: User:
Start: 07/23/21 End: 11/30/23 Due: 11/30/24

Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism

Phase: N/A Priority: Normal
NCT ID: NCT01673646 Org: User:
Start: 10/16/12 End: 04/10/17 Due: 04/10/18

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Phase: N/A Priority: Normal
NCT ID: NCT06855277 Org: User:
Start: 08/20/25 End: 11/04/32 Due: 11/04/33

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

Phase: N/A Priority: Normal
NCT ID: NCT06006559 Org: User:
Start: 02/20/24 End: 02/27/26 Due: 02/27/27